Myocardial infarction in sickle cell disease

Area of Science:

• Cardiology
• Hematology
• Internal Medicine

Background:

• Sickle cell disease (SCD) commonly causes organ damage through vasculo-occlusive crises.
• Myocardial infarction (MI) is a less commonly reported but significant complication in SCD patients.
• Diagnosis of MI in SCD is often delayed or missed due to overlapping symptoms and diagnostic challenges.

Purpose of the Study:

• To increase awareness of myocardial infarction (MI) as a complication in sickle cell disease (SCD).
• To review existing cases of MI in SCD patients.
• To prompt prospective research on treatment strategies for MI in SCD.

Main Methods:

• Retrospective review of 19 documented cases of myocardial infarction (MI) in patients with sickle cell disease (SCD).
• Analysis of diagnostic challenges, including the role of autopsy findings, electrocardiography, and cardiac enzyme interpretation.
• Examination of associated conditions and potential mechanisms of MI in SCD.

Main Results:

• Myocardial infarction (MI) is underdiagnosed in sickle cell disease (SCD), with many cases identified post-mortem.
• Electrocardiography and serum cardiac enzymes are often unreliable for diagnosing MI in SCD.
• MI in SCD is frequently associated with hypoxia, cor pulmonale, anemia, sepsis, acidosis, and renal failure.
• Coronary angiography is typically normal in these patients, suggesting non-atherosclerotic mechanisms.

Conclusions:

• Myocardial infarction (MI) is a serious, often overlooked, complication of sickle cell disease (SCD).
• Improved diagnostic approaches are needed to identify MI during the patient's lifetime.
• Further prospective studies are essential to develop targeted treatment strategies for MI in the SCD population.